Medtech Insight is part of Pharma Intelligence UK Limited

This site is operated by Pharma Intelligence UK Limited, a company registered in England and Wales with company number 13787459 whose registered office is 5 Howick Place, London SW1P 1WG. The Pharma Intelligence group is owned by Caerus Topco S.à r.l. and all copyright resides with the group.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By


Research Briefs: Robotic Leg; Bone-Mineral Density Tests; Diabetes; Sleep Apnea

This article was originally published in The Gray Sheet

Executive Summary

New prosthetic leg can receive signals from the patient’s nervous system to improve control. Study shows repeated bone-mineral density tests do not improve the prediction of osteoporosis-related injury.

You may also be interested in...

Sorin Gains Distribution Rights, Minority Stake In Respicardia’s remedē Sleep Apnea Device

Sorin’s $20 million investment will help Respicardia continue the U.S. pivotal trial of the remedē implantable phrenic nerve stimulator for sleep apnea and give Sorin exclusive rights to distribute the device in select European countries, where it has a CE mark but has yet to be launched.

Research In Brief

Targeted muscle reinnervation in prosthetic arms: Amputees' remaining arm muscles can be "reinnervated" to produce enough signals to control an artificial arm in real time, according to data from five patients treated at the Rehabilitation Institute of Chicago published in the Feb. 11 Journal of the American Medical Association. In the study, five people with shoulder disarticulation or transhumeral amputations underwent targeted muscle innervations; transfer of the remaining arm nerves to residual chest or upper-arm muscles transforms the muscles into "biological amplifiers" of motor commands from the transferred nerves. The target muscles produce electromyogram signals on the surface of the skin that can control an artificial elbow, wrist and hand, according to study author Todd A. Kuiken, M.D./Ph.D., Neural Engineering Center for Artificial Limbs, et al. The patients in the study were able to repeatedly perform 10 different elbow, wrist and hand motions with their artificial arm. The mean motion selection and motion completion times for elbow and wrist movements were 0.22 seconds and 1.29 seconds, respectively. These times were only 0.06 seconds and 0.21 seconds longer than the mean time for five non-amputee patients enrolled as the control group. In an accompanying editorial, Gerald E. Loeb, University of Southern California's Departments of Biomechanical Engineering and Neurology, calls Kuiken's results "exciting and promising." Loeb adds: "Such revolutions develop slowly at best, but their effects tend to be profound. With increasing functional capabilities, patients with upper-extremity amputations may derive exceptional benefit from prosthetic arms, just as legions of patients with lower-extremity amputations now lead remarkably normal and even athletic lives.

Recent And Upcoming FDA Advisory Committee Meetings

Recent and upcoming US FDA advisory committee meetings and a summary of topics covered. 


Related Companies

Latest News
See All



Ask The Analyst

Ask the Analyst is free for subscribers.  Submit your question and one of our analysts will be in touch.

Your question has been successfully sent to the email address below and we will get back as soon as possible. my@email.address.

All fields are required.

Please make sure all fields are completed.

Please make sure you have filled out all fields

Please make sure you have filled out all fields

Please enter a valid e-mail address

Please enter a valid Phone Number

Ask your question to our analysts